ROBA PHARMA
Board
1 director, no change since 2025Manager (not named in the articles), permanent representative
since 30-10-2018
term without a fixed end
also on the board of 4 other companies
listed in the 2025 annual accounts, filed on 15-07-2026
Permanent representatives 1
Mandates through the years
3 names, the dashed line is todayManager (not named in the articles)
Director
Manager (not named in the articles)
BoardOther functionEarlierend not dated
Mandates as a list
-
- Manager (not named in the articles), from 30-10-2018 to date
-
- Director, appointed by deed of 30-12-2025, still in office
-
- Manager (not named in the articles), from 30-10-2018 to 07-10-2025
- Manager (not named in the articles), appointed by deed of 05-11-2018, no longer listed in the 2025 annual accounts
Control
Founders
, ,
and 1 other
This company
ROBA PHARMA
Equity €311,875
Profit €3,538 in 2025
Capital
- Capital
- €18,600
- Shares
- 186
- Contribution per share
- €100
- Equity per share
- €1,677 in 2025
- Source
- deed of 05-11-2018
Articles of association
deed of 05-11-2018 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Zaakvoerders, door haar vast te stellen”
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Bevoegdheden en bezoldiging, algemene vergadering stelt een of meerdere vereffenaars aan”
Shareholders
At incorporation
deed of 05-11-2018 ↗
- 75 shares (40.3%) · €7,500 in cash
- 62 shares (33.3%) · €6,200 in cash
- 31 shares (16.7%) · €3,100 in cash
- 18 shares (9.7%) · €1,800 in cash